AG˹ٷ

STOCK TITAN

Microvast Reports First Quarter 2025 Financial Results

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
Microvast Holdings (NASDAQ:MVST) reported outstanding Q1 2025 financial results, achieving record Q1 revenue of $116.5 million, up 43.2% year-over-year. The company demonstrated significant profitability improvements with gross margin expanding to 36.9% from 21.2% in Q1 2024. Notable achievements include a net profit of $61.8 million compared to a $24.8 million loss in Q1 2024, and positive adjusted EBITDA of $28.5 million versus negative $3.7 million last year. Operating expenses decreased to $25.5 million from $40.9 million. The company's cash position strengthened to $123.0 million. For 2025, Microvast maintains its revenue growth target of 18-25% with guidance of $450-475 million and targets a 30% gross margin. The company plans to expand production capacity with Huzhou Phase 3.2, targeting first qualified products in Q4 2025.
Microvast Holdings (NASDAQ:MVST) ha riportato risultati finanziari eccezionali nel primo trimestre 2025, raggiungendo un fatturato record di 116,5 milioni di dollari, in crescita del 43,2% rispetto all'anno precedente. L'azienda ha mostrato significativi miglioramenti nella redditività con un margine lordo che si è ampliato al 36,9% rispetto al 21,2% del primo trimestre 2024. Tra i risultati più rilevanti si evidenzia un utile netto di 61,8 milioni di dollari rispetto a una perdita di 24,8 milioni nel primo trimestre 2024, e un EBITDA rettificato positivo di 28,5 milioni contro i -3,7 milioni dell'anno precedente. Le spese operative sono diminuite a 25,5 milioni rispetto a 40,9 milioni. La posizione di cassa si è rafforzata a 123,0 milioni di dollari. Per il 2025, Microvast conferma l'obiettivo di crescita del fatturato tra il 18 e il 25%, con una previsione di 450-475 milioni di dollari e punta a un margine lordo del 30%. L'azienda prevede di espandere la capacità produttiva con la fase 3.2 di Huzhou, con l'obiettivo di avere i primi prodotti qualificati nel quarto trimestre 2025.
Microvast Holdings (NASDAQ:MVST) reportó resultados financieros sobresalientes en el primer trimestre de 2025, alcanzando un ingreso récord de 116.5 millones de dólares, un aumento del 43.2% interanual. La compañía mostró mejoras significativas en la rentabilidad con un margen bruto que se expandió al 36.9% desde el 21.2% en el primer trimestre de 2024. Logros destacados incluyen una ganancia neta de 61.8 millones de dólares en comparación con una pérdida de 24.8 millones en el primer trimestre de 2024, y un EBITDA ajustado positivo de 28.5 millones frente a un negativo de 3.7 millones el año pasado. Los gastos operativos disminuyeron a 25.5 millones desde 40.9 millones. La posición de efectivo de la compañía se fortaleció a 123.0 millones. Para 2025, Microvast mantiene su objetivo de crecimiento de ingresos del 18-25% con una guía de 450-475 millones y apunta a un margen bruto del 30%. La empresa planea expandir la capacidad de producción con Huzhou Fase 3.2, con el objetivo de tener los primeros productos calificados en el cuarto trimestre de 2025.
Microvast Holdings(NASDAQ:MVST)� 2025� 1분기 뛰어� 재무 실적� 보고하며 1분기 매출� 1� 1,650� 달러� 사상 최고�� 기록, 전년 동기 대� 43.2% 증가했습니다. 회사� 매출 총이익률� 2024� 1분기 21.2%에서 36.9%� 크게 개선하며 수익� 향상� 입증했습니다. 주요 성과로는 2024� 1분기 2,480� 달러 손실에서 6,180� 달러 순이�으로 전환, 조정 EBITDA� 작년 마이너스 370� 달러에서 2,850� 달러 흑자� 전환했습니다. 영업비용은 4,090� 달러에서 2,550� 달러� 감소했습니다. 현금 보유액은 1� 2,300� 달러� 강화되었습니�. 2025� Microvast� 매출 성장 목표� 18~25%� 유지하며 4� 5,000만~4� 7,500� 달러 가이던스를 제시하고, 30% 매출 총이익률� 목표� 합니�. 회사� Huzhou 3.2단계 생산능력 확장� 계획 중이�, 2025� 4분기� � 번째 인증 제품 출하� 목표� 하고 있습니다.
Microvast Holdings (NASDAQ:MVST) a annoncé des résultats financiers exceptionnels pour le premier trimestre 2025, atteignant un chiffre d'affaires record de 116,5 millions de dollars, en hausse de 43,2 % par rapport à l'année précédente. La société a démontré une amélioration significative de sa rentabilité avec une marge brute passant à 36,9 % contre 21,2 % au premier trimestre 2024. Parmi les réalisations notables figurent un bénéfice net de 61,8 millions de dollars contre une perte de 24,8 millions au premier trimestre 2024, ainsi qu'un EBITDA ajusté positif de 28,5 millions contre un négatif de 3,7 millions l'année dernière. Les dépenses d'exploitation ont diminué à 25,5 millions contre 40,9 millions. La trésorerie de l'entreprise s'est renforcée à 123,0 millions de dollars. Pour 2025, Microvast maintient son objectif de croissance du chiffre d'affaires entre 18 et 25 %, avec une prévision de 450 à 475 millions de dollars, et vise une marge brute de 30 %. La société prévoit d'élargir sa capacité de production avec la phase 3.2 de Huzhou, visant les premiers produits qualifiés au quatrième trimestre 2025.
Microvast Holdings (NASDAQ:MVST) meldete herausragende Finanzergebnisse für das erste Quartal 2025 und erzielte einen rekordverdächtigen Q1-Umsatz von 116,5 Millionen US-Dollar, was einem Anstieg von 43,2 % gegenüber dem Vorjahr entspricht. Das Unternehmen zeigte deutliche Verbesserungen der Rentabilität mit einer Bruttomarge, die von 21,2 % im Q1 2024 auf 36,9 % anstieg. Zu den bemerkenswerten Erfolgen zählen ein Nettoergebnis von 61,8 Millionen US-Dollar im Vergleich zu einem Verlust von 24,8 Millionen im Q1 2024 sowie ein positives bereinigtes EBITDA von 28,5 Millionen gegenüber minus 3,7 Millionen im Vorjahr. Die Betriebskosten sanken von 40,9 auf 25,5 Millionen US-Dollar. Die Barreserven des Unternehmens stärkten sich auf 123,0 Millionen US-Dollar. Für 2025 hält Microvast an seinem Umsatzziel von 18-25 % Wachstum mit einer Prognose von 450-475 Millionen US-Dollar fest und strebt eine Bruttomarge von 30 % an. Das Unternehmen plant, die Produktionskapazität mit der Phase 3.2 in Huzhou auszubauen und zielt darauf ab, im vierten Quartal 2025 die ersten qualifizierten Produkte zu liefern.
Positive
  • Record Q1 revenue of $116.5M, up 43.2% YoY
  • Significant gross margin improvement to 36.9% from 21.2%
  • Net profit of $61.8M vs net loss of $24.8M in Q1 2024
  • Positive adjusted EBITDA of $28.5M vs negative $3.7M in Q1 2024
  • Strong cash position of $123.0M, up from $109.6M in December 2024
  • Operating expenses reduced to $25.5M from $40.9M YoY
Negative
  • Capital expenditures may increase with Huzhou Phase 3.2 expansion
  • Projected revenue growth for 2025 (18-25%) is lower than Q1's growth rate (43.2%)
  • Target gross margin of 30% for 2025 is below Q1's 36.9%

Insights

Microvast achieved remarkable Q1 turnaround with 43.2% revenue growth and shift to profitability, signaling successful execution of business strategy.

Microvast's Q1 2025 results represent a dramatic financial transformation, with the battery technology company achieving both record revenue and a significant profit inflection point. The $116.5 million revenue marks a 43.2% year-over-year increase, substantially outpacing the broader EV supply chain sector. Most impressive is the 15.7% gross margin expansion to 36.9%, indicating strong pricing power and operational efficiency improvements.

The net profit of $61.8 million represents a decisive break from the $24.8 million loss in Q1 2024. While extraordinary items likely influenced this figure (given the $19.3 million adjusted net profit), the transition to positive territory on both metrics demonstrates fundamental business improvement. The positive adjusted EBITDA of $28.5 million versus negative $3.7 million last year confirms this operational turnaround.

Microvast's cash position has strengthened considerably, with $123 million in cash and equivalents, up from $109.6 million at year-end 2024. This 12.2% increase in just one quarter provides enhanced financial flexibility for the expansion plans outlined in their capacity growth strategy. The reduced capital expenditures ($6.6 million vs. $10.2 million in Q1 2024) suggest more disciplined capital allocation while still investing in growth.

Management's maintained 2025 revenue guidance of $450-475 million (representing 18-25% growth) alongside a targeted 30% gross margin suggests continued confidence in their business trajectory. The planned Huzhou Phase 3.2 capacity expansion indicates strong demand signals from customers, reinforcing the commercial validation of their battery technology in specialized vehicle markets.

  • Record company Q1 revenue, increased 43.2% year over year to $116.5 million
  • Gross margin increased from 21.2% to 36.9%, a 15.7 percentage point improvement year over year

STAFFORD, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast� or the “Company�), a global leader in advanced battery technologies, announced today its unaudited condensed consolidated financial results for the first quarter ended March 31, 2025 (“Q1 2025�).

"Building on our strong momentum from 2024, Microvast delivered exceptional first quarter results, achieving record Q1 revenue of $116.5 million, a significant 43.2% year over year increase. This impressive top-line growth is coupled with a substantial expansion in gross margin to 36.9%. For the quarter we booked a net profit of $61.8 million and a positive adjusted EBITDA of $28.5 million, underscoring the increasing demand for our advanced battery solutions and the effectiveness of our focus on profitability and operational efficiency," said Yang Wu, Microvast’s Founder, Chairman, and Chief Executive Officer.

Results for Q1 2025

  • Record first quarter revenue of $116.5 million, compared to $81.4 million in Q1 2024, an increase of 43.2%

  • Gross margin increased to 36.9% from 21.2% in Q1 2024; Non-GAAP adjusted gross margin increased to 37.0%, up from 22.6% in Q1 2024

  • Operating expenses of $25.5 million, compared to $40.9 million in Q1 2024; Non-GAAP adjusted operating expenses of $24.9 million, compared to $30.1 million in Q1 2024

  • Net profit of $61.8 million, compared to net loss of $24.8 million in Q1 2024; Non-GAAP adjusted net profit of $19.3 million, compared to non-GAAP adjusted net loss of $13.0 million in Q1 2024

  • Net profit per share of $0.19 compared to net loss per share of $0.08 in Q1 2024; Non-GAAP adjusted net profit per share of $0.06, compared to non-GAAP adjusted net loss per share of $0.04 in Q1 2024

  • Non-GAAP adjusted EBITDA of positive $28.5 million in Q1 2025, compared to non-GAAP adjusted EBITDA of negative $3.7 million in Q1 2024

  • Capital expenditures of $6.6 million, compared to $10.2 million in Q1 2024

  • Cash, cash equivalents, restricted cash and short-term investments of $123.0 million as of March31, 2025, compared to $109.6 million as of December31, 2024, and $86.7 million as of March31, 2024

Please refer to the tables at the end of this press release for reconciliations of gross profit to non-GAAP adjusted gross profit, operating expenses to non-GAAP adjusted operating expenses, net profit/(loss) to non-GAAP adjusted net profit/(loss), net profit/(loss) to non-GAAP adjusted EBITDA and gross margin to non-GAAP adjusted gross margin.

2025 Outlook

  • For the remainder of 2025, the Company maintains its target revenue growth of 18% to 25% year over year and revenue guidance of $450 million to $475 million

  • Through 2025, with continued regional efficiencies and utilization increases, the Company is targeting a gross margin of 30%

  • Installation of production equipment for Huzhou Phase 3.2, increasing our capacity to meet strong customer demand and targeting first qualified products in Q4 2025

  • Sustained focus on new customer wins that will continue to expand our presence in differentiated commercial vehicle markets as OEM product lines and segments continue to electrify

Webcast Information

Company management will host a conference call and webcast on May12, 2025, at 4:00 p.m. Central Time, to discuss the Company's financial results. The live webcast and accompanying slide presentation will be accessible from the Events & Presentations section of Microvast’s investor relations website (). A replay will be available following the conclusion of the event.

About Microvast

Microvast is a global leader in providing battery technologies for electric vehicles and energy storage solutions. With a legacy of over 18 years, Microvast has consistently delivered cutting-edge battery systems that empower a cleaner and more sustainable future. The company's innovative approach and dedication to excellence have positioned it as a trusted partner for customers around the world. Founded in 2006 in Stafford, Texas, Microvast holds more than 810 patents and patent applications that enable solutions for today’s electrification needs.

For more information, please visit or follow us on LinkedIn (@microvast).

Contact:

Investor Relations
[email protected]

Cautionary Statement Regarding Forward-Looking Statements

This communication contains “forward-looking statements� within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about our future results of operations and financial position, our operational performance, our anticipated growth and business strategy, our future capital expenditures and debt service obligations, the projected costs, prospects and plans and objectives of management for future operations, including regarding expected growth and demand for our batteries and energy storage solutions and introduction of new batteries and energy storage solutions, the adoption of such offerings by customers, our expectations relating to backlog, pipeline and contracted backlog, our ability to implement our remediation plan in connection with the material weakness in our internal control over financial reporting, current expectations relating to legal proceedings and anticipated impacts and benefits from the Inflation Reduction Act of 2022 as well as any other proposed or recently enacted legislation. In some cases, you may also identify forward-looking statements by words such as “anticipate,� “believe,� “continue,� “could,� “estimate,� “expect,� “intend,� “may,� “might,� “objective,� “plan,� “project,� “predict,� “outlook� “should,� “will,� “would,� or the negative of these terms, or other comparable terminology intended to identify statements about the future. Such forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.

Many factors could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements, including, among others: (1) our ability to remain a going concern; (2) risk that we may not be able to execute our growth strategies or achieve profitability; (3) risk that we will be unable to raise additional capital to execute our business plan or pay our debts as they come due, which may not be available on acceptable terms or at all; (4) potential difficulties in maintaining manufacturing capacity and establishing expected mass manufacturing capacity in the future; (5) risks relating to delays, disruptions and quality control problems in our manufacturing operations; (6) restrictions in our existing and any future credit facilities; (7) risks of operations in China; (8) the effects of mechanics liens filed by contractors that we do not have sufficient funds to pay; (9) the effects of existing and future litigation; (10) changes in general economic conditions, including increases in interest rates and associated Federal Reserve policies, a potential economic recession, and the impact of inflation on our business; (11) changes in the highly competitive market in which we compete, including with respect to our competitive landscape, technology evolution or regulatory changes; (12) changes in availability and price of raw materials; (13) labor relations, including the ability to attract, hire and retain key employees and contract personnel; (14) heightened awareness of environmental issues and concern about global warming and climate change; (15) risk that we are unable to secure or protect our intellectual property; (16) risk that our customers or third-party suppliers are unable to meet their obligations fully or in a timely manner; (17) risks related to possible future reductions in pricing or order volume or loss of one or more of our significant customers; (18) risks relating to our status as a relatively low-volume purchaser as well as from supplier concentration and limited supplier capacity; (19) risk that our customers will adjust, cancel or suspend their orders for our products; (20) risk of product liability or regulatory lawsuits or proceedings relating to our products or services; (21) our ability to maintain and enhance our reputation and brand recognition; (22) the effectiveness of our information technology and operational technology systems and practices to detect and defend against evolving cyberattacks; (23) changing laws regarding cybersecurity and data privacy, and any cybersecurity threat or event; (24) the effects and associated cost of compliance with existing and future laws and governmental regulations, such as the Inflation Reduction Act; (25) risks relating to whether renewable energy technologies are suitable for widespread adoption or if sufficient demand for our offerings does not develop or takes longer to develop than we anticipate; (26) economic, financial and other impacts such as a pandemic, including global supply chain disruptions; (27) the impacts of geopolitical events, including the ongoing conflicts between Russia and Ukraine and in the Middle East; and (28) Tariffs imposed on products of the PRC into the United States may lead to increased costs and impact our business. Microvast’s annual, quarterly and other filings with the U.S. Securities and Exchange Commission identify, address and discuss these and other factors in the sections entitled “Risk Factors.�

Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control.

All information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date hereof except as may be required under applicable securities laws. Forecasts and estimates regarding our industry and end markets are based on sources we believe to be reliable, however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

All references to the “Company,� “we,� “us� or “our� refer to Microvast Holdings, Inc. and its consolidated subsidiaries other than certain historical information which refers to the business of Microvast prior to the consummation of the Business Combination.

Non-GAAP Financial Measures

To provide investors with additional information regarding our financial results, Microvast has disclosed in this earnings release non-GAAP financial measures, including non-GAAP adjusted gross profit, non-GAAP adjusted EBITDA, non-GAAP adjusted operating expenses, non-GAAP adjusted net profit/(loss) and non-GAAP adjusted gross margin which are non-GAAP financial measures as defined under the rules of the SEC. These are intended as supplemental measures of our financial performance that are not required by, or presented in accordance with U.S. generally accepted accounting principles (“GAAP�).

Reconciliations to the most comparable GAAP measures, gross profit, gross margin, operating expenses and net profit/(loss), are contained in tabular form in the unaudited financial statements below. Non-GAAP adjusted gross profit is GAAP gross profit as adjusted for non-cash stock-based compensation expense included in cost of revenues. Non-GAAP adjusted net profit/(loss) is GAAP net profit/(loss) as adjusted for non-cash stock-based compensation expense and change in valuation of warrant and Convertible loan. Non-GAAP adjusted net profit/(loss) per common share is GAAP net profit/(loss) per common share as adjusted for non-cash stock-based compensation expense and change in valuation of warrant and Convertible loan per common share. Non-GAAP adjusted EBITDA is defined as net profit/(loss) excluding depreciation and amortization, non-cash settled share-based compensation expense, interest expense, interest income, changes in fair value of our warrant and Convertible loan and income tax expense or benefit. Non-GAAP adjusted operating expenses is defined as operating expenses excluding non-cash stock-based compensation expense. Non-GAAP adjusted gross margin is defined as GAAP gross margin as adjusted for non-cash stock-based compensation expense included in cost of revenues.

We use non-GAAP adjusted gross profit, non-GAAP adjusted EBITDA, non-GAAP adjusted operating expenses, non-GAAP adjusted net profit/(loss) and non-GAAP adjusted gross margin for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We consider them to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis. We believe that these non-GAAP financial measures, when taken together with their most directly comparable GAAP measures, gross profit and net profit/(loss), provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results.

We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors.

Non-GAAP financial measures have limitations as an analytical tool, and you should not consider them in isolation, or as a substitute for, financial information prepared in accordance with GAAP. For example, our calculation of non-GAAP adjusted EBITDA may differ from similarly titled non-GAAP measures, if any, reported by our peer companies, or our peer companies may use other measures to calculate their financial performance, and therefore our use of non-GAAP adjusted EBITDA may not be directly comparable to similarly titled measures of other companies. The principal limitation of non-GAAP adjusted EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements. In addition, it is subject to inherent limitations as it reflects the exercise of judgments by management about which expense and income are excluded or included in determining this non-GAAP financial measure. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. In addition, such financial information is unaudited and does not conform to SEC Regulation S-X and as a result, such information may be presented differently in our future filings with the SEC. For example, with respect to the warrant liability resulting from the merger, we now exclude changes in fair value from net profit/(loss) in our non-GAAP adjusted EBITDA and non-GAAP adjusted net profit/(loss) calculation, which had not been done in prior periods.

MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
March 31,
2025
December 31,
2024
Assets
Current assets:
Cash and cash equivalents$90,898$73,007
Restricted cash, current32,09636,572
Accounts receivable (net of allowance for credit losses of $6,523 and $5,090 as of March31, 2025 and December31, 2024, respectively)135,654120,626
Notes receivable10,3627,579
Inventories, net129,059143,327
Prepaid expenses and other current assets30,02727,019
Assets held for sale19,89619,896
Total Current Assets447,992428,026
Restricted cash, non-current22
Property, plant and equipment, net485,157478,189
Land use rights, net11,36611,371
Acquired intangible assets, net2,4962,607
Operating lease right-of-use assets18,20517,628
Other non-current assets17,71614,024
Total Assets$982,932$951,867
Liabilities
Current liabilities:
Accounts payable$56,771$64,940
Advance from customers44,20443,678
Accrued expenses and other current liabilities104,13698,456
Amounts due to related parties5
Income tax payables653652
Short-term bank borrowings86,24170,666
Notes payable47,90151,756
Total Current Liabilities339,906330,153
Long-term bonds payable41,69343,157
Long-term bank borrowings41,30241,062
Warrant liability64290
Share-based compensation liability9898
Operating lease liabilities14,79314,596
Convertible loan measured at fair value60,996104,613
Other non-current liabilities29,84530,003
Total Liabilities$528,697$563,972
Stockholders� Equity
Common Stock (par value of US$0.0001 per share, 750,000,000 and 750,000,000 shares authorized as of March31, 2025 and December31, 2024; 325,216,389 and 324,831,634 shares issued, and 323,528,889 and 323,144,134 shares outstanding as of March31, 2025 and December31, 2024)$33$33
Additional paid-in capital1,513,6851,512,982
Statutory reserves6,0326,032
Accumulated deficit(1,031,168)(1,092,958)
Accumulated other comprehensive loss(34,347)(38,194)
Total Equity$454,235$387,895
Total Liabilities and Equity$982,932$951,867


MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
Three Months Ended
March 31,
20252024
Revenues$116,491$81,351
Cost of revenues(73,475)(64,126)
Gross profit43,01617,225
Operating expenses:
General and administrative expenses(10,453)(23,794)
Research and development expenses(8,248)(11,492)
Selling and marketing expenses(6,799)(5,591)
Total operating expenses(25,500)(40,877)
Subsidy income1,416534
Profit/(loss) from operations18,932(23,118)
Other income and expenses:
Interest income177119
Interest expense(1,188)(1,732)
Changes in fair value of warrant liability and convertible loan43,16042
Gain on debt restructuring389
Other income/(expense), net320(136)
Profit/(loss) before provision for income taxes61,790(24,825)
Income tax expense
Net profit/(loss)$61,790$(24,825)
Less: net profit/(loss) attributable to noncontrolling interests
Net profit/(loss) attributable to Microvast Holdings, Inc.'s stockholders$61,790$(24,825)
Net profit/(loss) per common share
Basic$0.19$(0.08)
Diluted$0.05$(0.08)
Weighted average shares used in calculating net profit/(loss) per share of common stock
Basic323,430,721315,367,121
Diluted374,425,026315,367,121


MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
Three Months Ended March 31,
20252024
Cash flows from operating activities
Net profit/(loss)$61,790$(24,825)
Adjustments to reconcile net profit/(loss) to net cash used in operating activities:
Loss/(gain) on disposal of property, plant and equipment95(34)
Gain on debt restructuring(389)
Depreciation of property, plant and equipment7,9857,470
Amortization of land use right and intangible assets192194
Noncash lease expenses666664
Share-based compensation70311,865
Changes in fair value of warrant and convertible loan(43,160)(42)
Allowance of credit losses1,358578
Product warranty4,8253,269
Changes in operating assets and liabilities:
Notes receivable(5,263)10,577
Accounts receivable(14,108)12,011
Inventories15,78316,341
Prepaid expenses and other current assets(2,402)4,305
Amounts due to related parties(5)
Operating lease right-of-use assets(654)(323)
Other non-current assets(1,388)(275)
Notes payable(4,150)1,042
Accounts payable(8,547)(27,843)
Advance from customers462(1,694)
Accrued expenses and other liabilities(6,812)(10,623)
Operating lease liabilities(340)(500)
Other non-current liabilities528(126)
Net cash generated from operating activities7,1692,031
Cash flows from investing activities
Purchases of property, plant and equipment(2,346)(10,241)
Proceeds on disposal of property, plant and equipment14152
Proceeds from maturity of short-term investments5,564
Net cash used in investing activities(2,332)(4,525)


MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS-Continued
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
Three Months Ended
March 31,
20252024
Cash flows from financing activities
Proceeds from borrowings28,18718,780
Repayment of bank borrowings(13,062)(12,520)
Repayment of bonds payable(1,375)
Deferred payment related to purchases of property, plant and equipment(4,287)
Net cash generated from financing activities9,4636,260
Effect of exchange rate changes(907)(5,251)
Increase/ (decrease) in cash, cash equivalents and restricted cash13,393(1,485)
Cash, cash equivalents and restricted cash at beginning of the period109,60188,189
Cash, cash equivalents and restricted cash at end of the period$122,994$86,704


Three Months Ended
March 31,
20252024
Reconciliation to amounts on consolidated balance sheets
Cash and cash equivalents$90,898$39,451
Restricted cash32,09647,253
Total cash, cash equivalents and restricted cash$122,994$86,704


MICROVAST HOLDINGS, INC.
RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT
(Unaudited, in thousands of U.S. dollars)
Three Months Ended
March 31,
20252024
Revenues$116,491$81,351
Cost of revenues(73,475)(64,126)
Gross profit (GAAP)$43,016$17,225
Gross margin36.9%21.2%
Non-cash settled share-based compensation (included in cost of revenues)621,138
Adjusted gross profit (non-GAAP)$43,078$18,363
Adjusted gross margin (non-GAAP)37.0%22.6%


MICROVAST HOLDINGS, INC.
RECONCILIATION OF OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES
(Unaudited, in thousands of U.S. dollars)
Three Months Ended
March 31,
20252024
General and administrative expenses(10,453)(23,794)
Research and development expenses(8,248)(11,492)
Selling and marketing expenses(6,799)(5,591)
Operating expenses (GAAP)$(25,500)$(40,877)
Non-cash settled share-based compensation (included in Operating expenses)64110,729
Adjusted operating expenses (non-GAAP)$(24,859)$(30,148)


MICROVAST HOLDINGS, INC.
RECONCILIATION OF NET PROFIT/(LOSS) TO ADJUSTED NET PROFIT/(LOSS)
(Unaudited, in thousands of U.S. dollars, except per share data, or as otherwise noted)
Three Months Ended
March 31,
20252024
Net profit/(loss) (GAAP)$61,790$(24,825)
Changes in fair value of warrant and Convertible loan*(43,160)(42)
Non-cash settled share-based compensation*70311,867
Adjusted net profit/(loss) (non-GAAP)$19,333$(13,000)

*The tax effect of the adjustments was nil.

Three Months Ended
March 31,
20252024
Net profit/(loss) per common share-Basic (GAAP)$0.19$(0.08)
Changes in fair value of warrant and Convertible loan per common share(0.13)
Non-cash settled share-based compensation per common share0.04
Adjusted net profit/(loss) per common share-Basic (non-GAAP)$0.06$(0.04)


MICROVAST HOLDINGS, INC.
RECONCILIATION OF NET PROFIT/(LOSS) TO EBITDA AND ADJUSTED EBITDA
(Unaudited, in thousands of U.S. dollars)
Three Months Ended
March 31,
20252024
Net profit/(loss) (GAAP)$61,790$(24,825)
Interest expense (income), net1,0111,613
Income tax expense
Depreciation and amortization8,1777,664
EBITDA (non-GAAP)$70,978$(15,548)
Changes in fair value of warrant liability and convertible loan(43,160)(42)
Non-cash settled share-based compensation70311,867
Adjusted EBITDA (non-GAAP)$28,521$(3,723)

FAQ

What was Microvast's (MVST) revenue growth in Q1 2025?

Microvast reported record Q1 revenue of $116.5 million, representing a 43.2% increase compared to $81.4 million in Q1 2024.

How much profit did MVST make in Q1 2025?

Microvast reported a net profit of $61.8 million in Q1 2025, compared to a net loss of $24.8 million in Q1 2024, with earnings per share of $0.19.

What is Microvast's revenue guidance for 2025?

Microvast maintains its 2025 revenue guidance of $450-475 million, targeting year-over-year growth of 18-25%.

How much did MVST's gross margin improve in Q1 2025?

Microvast's gross margin increased significantly to 36.9% in Q1 2025 from 21.2% in Q1 2024, representing a 15.7 percentage point improvement.

What is Microvast's cash position as of Q1 2025?

As of March 31, 2025, Microvast had $123.0 million in cash, cash equivalents, restricted cash and short-term investments, up from $109.6 million at the end of 2024.
Microvast Holdings Inc

NASDAQ:MVST

MVST Rankings

MVST Latest News

MVST Latest SEC Filings

MVST Stock Data

847.51M
196.09M
39.75%
11.39%
9.49%
Auto Parts
Miscellaneous Electrical Machinery, Equipment & Supplies
United States
STAFFORD